Maculopathy Associated With Combination Chemotherapy and Osmotic Opening of the Blood-Brain Barrier

This publication has 17 references indexed in Scilit:

• Therapeutic Efficacy of Multiagent Chemotherapy with Drug Delivery Enhancement by Blood-Brain Barrier Modification in Glioblastoma
  Neurosurgery, 1986
• Ocular and Orbital Toxicity Following Intracarotid Injection of BCNU (Carmustine) and Cisplatinum for Malignant Gliomas
  Ophthalmology, 1985
• Neurotoxicity of chemotherapeutic agents after blood‐brain barrier modification: Neuropathological studies
  Annals of Neurology, 1983
• Successful Treatment of Primary Central Nervous System Lymphomas with Chemotherapy after Osmotic Blood-Brain Barrier Opening
  Neurosurgery, 1983
• Ocular Toxicity Associated With High-Dose Carmustine
  Archives of Ophthalmology (1950), 1982
• Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.
  Proceedings of the National Academy of Sciences, 1982
• Limitations of High Dose Intra-arterial 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU) Chemotherapy for Malignant Gliomas
  Neurosurgery, 1982
• Monitoring of Methotrexate Delivery in Patients with Malignant Brain Tumors After Osmotic Blood-Brain Barrier Disruption
  Annals of Internal Medicine, 1981
• Effect of Osmotic Blood-Brain Barrier Disruption on Methotrexate Pharmacokinetics in the Dog
  Neurosurgery, 1980
• Is There a Therapeutic Role for Blood-Brain Barrier Disruption?
  Annals of Internal Medicine, 1980